ClexBio is a seed startup based in Norway. 1 investor tracked.
ClexBio is a company founded in 2018 headquartered in Germany. Its most recent tracked round is Seed. Brouky records 2 investors associated with the company.
ClexBio develops a novel technology for high-throughput 3D cell culture and organoid generation. Their platform aims to create more physiologically relevant models for drug discovery and regenerative medicine applications.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.